Rethinking diagnostics in the fight against antimicrobial resistance
Alejandra Sanchez and Ben Wicks explore why primary care needs timely, pragmatic insight, not lab-grade certainty, to enable better antibiotic decisions and stewardship.
Unlocking the potential of IP-free gene editing to gain commercial advantage
CC’s transdisciplinary development team has created a way to democratise gene editing. This IP-free gene editing method avoids the timescales and costs involved with commercially licensing current CRISPR/Cas9 editing techniques.
Engineering biology is driving the new bio-industrial revolution
Engineering biology, the fusion of biology and engineering principles, will be key to solving some of humanity’s most urgent challenges – from climate change and food security to healthcare and more
Quantum computing in 2025: from dream to deployment
Quantum computing has moved from theory and science fiction to become a strategy for business growth, with transformative rewards for those willing to engage with its complexities
次世代オートインジェクター：患者・製薬企業・保険者・地球環境のニーズの調和
ケンブリッジコンサルタンツ開発チームから、再使用可能なオートインジェクターの事例を通じて、患者、製薬企業、保険者、地球環境のそれぞれに価値をもたらす製品開発アプローチを紹介します。
How digital twin innovation can accelerate healthcare product development
Deep tech consultants explore the challenges and rewards of implementing a digital twin prototype to accelerate healthcare product development